Press Releases Integrated BioPharma, Inc.

Equities

INBP

US45811V1052

Market Closed - OTC Markets Other stock markets 18:46:54 14/05/2024 BST			5-day change	1st Jan Change
0.22 ^USD	+1.38%		+0.82%	-10.28%

05-10	Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-12	Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024	05-13	AQ
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)	21/03/23	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/23	AQ
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	28/11/22	PU
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	28/11/22	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/11/22	AQ
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	24/10/22	AQ
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)	13/09/22	AQ
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)	15/07/22	AQ
Integrated BioPharma : Announces Change in Directors - Form 8-K	21/06/22	PU
INTEGRATED BIOPHARMA INC : Financial Statements and Exhibits (form 8-K)	21/06/22	AQ
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibits (form 8-K)	12/05/22	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	12/05/22	AQ
Integrated BioPharma : Reports Results for its Quarter Ended December 31, 2022 - Form 8-K	10/02/22	PU
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/22	AQ
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	29/11/21	PU
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	29/11/21	AQ
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021 - Form 8-K	10/11/21	PU
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/11/21	AQ
Integrated BioPharma : Reports Results for its Quarter and Fiscal Year Ended June 30, 2021 (Form 8-K)	02/09/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Integrated BioPharma, Inc.

Equities

INBP

US45811V1052

Press Releases

Filters